Commitments and Contingencies (Tables)

3 Months Ended

12 Months Ended

Sep. 30, 2016

Jun. 30, 2016

Commitments and Contingencies Disclosure [Abstract]

Commitments And Contingencies Disclosure [Table Text Block]

Commitments and contingencies are described below and summarized by the following table for the designated fiscal years ending June 30, as of September 30, 2016:

			Remaining
	Total		2017		2018		2019		2020		2021		Thereafter
Prescription Database	$	1,902,000	$	731,000	$	598,000	$	573,000	$	—	$	—	$	—
Natesto		8,500,000		6,000,000		—		—		2,500,000		—		—
Manufacturing agreement		2,500,000		1,500,000		500,000		500,000		—		—		—
ProstaScint commercial supply agreement		1,673,000		1,569,000		102,000		2,000
Service agreement		153,000		153,000		—		—		—		—		—
Primsol		250,000		250,000		—		—		—		—		—
Office Lease		283,000		108,000		145,000		30,000		—		—		—
Sponsored research agreement with related party		60,000		60,000		—		—		—		—		—
	$	15,321,000	$	10,371,000	$	1,345,000	$	1,105,000	$	2,500,000	$	—	$	—

Commitments and contingencies are described below and summarized by the following table as of June 30, 2016:

	Total		2017		2018		2019		2020		2021		Thereafter
Prescription Database	$	1,902,000	$	731,000	$	598,000	$	573,000	$	—	$	—	$	—
Natesto		8,500,000		6,000,000		—		—		2,500,000		—		—
Manufacturing agreement		3,000,000		2,000,000		500,000		500,000		—		—		—
Service agreement		204,000		204,000		—		—		—		—		—
Primsol		750,000		750,000		—		—		—		—		—
Office Lease		317,000		142,000		145,000		30,000		—		—		—
Sponsored research agreement with related party		70,000		70,000		—		—		—		—		—
	$	14,743,000	$	9,897,000	$	1,243,000	$	1,103,000	$	2,500,000	$	—	$	—

Schedule of Rent Expense [Table Text Block]

Rent expense for the respective periods is as follows:

	Three Months Ended September 30,
	2016		2015
Rent expense	$	35,000	$	18,000

Rent expense for the respective periods is as follows:

	Year Ended June 30,
	2016		2015
Rent expense	$	120,000	$	51,000